In the current study, we investigated the expression pattern of TIGIT in NK cells derived from bone marrow specimens of newly diagnosed CBF-AML patients and analyzed its impacts on NK cell function and patient outcomes. This evidence concerns the gene CEBPZ and acute myeloid leukemia.